Urology Annals
About UA | Search | Ahead of print | Current Issue | Archives | Instructions | Online submissionLogin 
Urology Annals
  Editorial Board | Subscribe | Advertise | Contact
Users Online: 724   Home Print this page  Email this page Small font size Default font size Increase font size
CASE REPORT
Year : 2017  |  Volume : 9  |  Issue : 2  |  Page : 194-196

One year survivor of metastatic renal cell carcinoma treated with pazopanib


1 Department of Surgical, Urology Unit, UKM Medical Center, 56000 Cheras, Kuala Lumpur, Malaysia
2 Department of Radiology, UKM Medical Center, 56000 Cheras, Kuala Lumpur, Malaysia

Correspondence Address:
Fam Xeng Inn
Department of Surgical, UKM Medical Center, Jalan Yaacob Latif, Bandar Tun Razak, 56000 Cheras, Kuala Lumpur
Malaysia
Login to access the Email id


DOI: 10.4103/0974-7796.204178

PMID: 28479777

Rights and Permissions

Tyrosine kinase inhibitor (TKI) and its side effects are well known. However, these are mainly descriptive, with pictorial data lacking. Here, in we report a case of metastatic renal cell carcinoma, treated with TKI, with classic side effects; supplemented with images that demonstrate the adverse effects of the drug. In addition, we discuss and demonstrate the computed tomography changes.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1801    
    Printed22    
    Emailed0    
    PDF Downloaded189    
    Comments [Add]    

Recommend this journal